Interpretation of Incidence Rates Data
Incidence Rate Report by State
Non-Hodgkin Lymphoma (Late Stage^), 2017-2021
All Races (includes Hispanic), Both Sexes, All Ages
Sorted by Ruralurban
Explanation of Column HeadersObjective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.
Other Notes
- Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
- Data is currently being suppressed if there are fewer than 16 counts for the time period.
Line by Line Interpretation of the Report
US (SEER+NPCR)1
- Rate : The incidence rate is 12.0 with a 95% confidence interval from 12.0 to 12.1 and 46,520 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 65.0
District of Columbia6
- Rate : The incidence rate is 9.5 with a 95% confidence interval from 8.5 to 10.6 and 64 average annual cases over 2017-2021.
- CI*Rank ⋔ : 47 (38, 49)
- Percent of Cases with Late Stage : 60.5
Puerto Rico6
- Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.1 to 5.8 and 222 average annual cases over 2017-2021.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : 39.8
Alabama6
- Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.5 and 567 average annual cases over 2017-2021.
- CI*Rank ⋔ : 48 (44, 48)
- Percent of Cases with Late Stage : 63.8
Alaska6
- Rate : The incidence rate is 11.9 with a 95% confidence interval from 10.7 to 13.1 and 85 average annual cases over 2017-2021.
- CI*Rank ⋔ : 32 (4, 43)
- Percent of Cases with Late Stage : 66.4
Arizona6
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.9 and 851 average annual cases over 2017-2021.
- CI*Rank ⋔ : 45 (43, 48)
- Percent of Cases with Late Stage : 63.1
Arkansas6
- Rate : The incidence rate is 10.9 with a 95% confidence interval from 10.4 to 11.4 and 407 average annual cases over 2017-2021.
- CI*Rank ⋔ : 39 (33, 44)
- Percent of Cases with Late Stage : 62.9
California3
- Rate : The incidence rate is 11.9 with a 95% confidence interval from 11.8 to 12.0 and 5,226 average annual cases over 2017-2021.
- CI*Rank ⋔ : 30 (27, 35)
- Percent of Cases with Late Stage : 67.4
Colorado6
- Rate : The incidence rate is 11.4 with a 95% confidence interval from 11.0 to 11.7 and 713 average annual cases over 2017-2021.
- CI*Rank ⋔ : 37 (30, 39)
- Percent of Cases with Late Stage : 68.9
Connecticut3
- Rate : The incidence rate is 13.4 with a 95% confidence interval from 12.9 to 13.8 and 617 average annual cases over 2017-2021.
- CI*Rank ⋔ : 8 (3, 20)
- Percent of Cases with Late Stage : 65.3
Delaware6
- Rate : The incidence rate is 11.9 with a 95% confidence interval from 11.0 to 12.8 and 158 average annual cases over 2017-2021.
- CI*Rank ⋔ : 31 (9, 40)
- Percent of Cases with Late Stage : 69.9
Florida6
- Rate : The incidence rate is 12.1 with a 95% confidence interval from 12.0 to 12.3 and 3,616 average annual cases over 2017-2021.
- CI*Rank ⋔ : 29 (22, 32)
- Percent of Cases with Late Stage : 55.5
Georgia3
- Rate : The incidence rate is 11.6 with a 95% confidence interval from 11.3 to 11.9 and 1,336 average annual cases over 2017-2021.
- CI*Rank ⋔ : 35 (29, 37)
- Percent of Cases with Late Stage : 66.9
Hawaii3
- Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.2 to 10.5 and 187 average annual cases over 2017-2021.
- CI*Rank ⋔ : 44 (39, 48)
- Percent of Cases with Late Stage : 64.3
Idaho3
- Rate : The incidence rate is 12.8 with a 95% confidence interval from 12.1 to 13.5 and 273 average annual cases over 2017-2021.
- CI*Rank ⋔ : 14 (4, 33)
- Percent of Cases with Late Stage : 68.6
Illinois3
- Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.4 to 13.0 and 1,933 average annual cases over 2017-2021.
- CI*Rank ⋔ : 16 (10, 27)
- Percent of Cases with Late Stage : 67.3
Iowa3
- Rate : The incidence rate is 14.9 with a 95% confidence interval from 14.3 to 15.4 and 591 average annual cases over 2017-2021.
- CI*Rank ⋔ : 1 (1, 3)
- Percent of Cases with Late Stage : 70.1
Kansas6
- Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.7 to 12.8 and 425 average annual cases over 2017-2021.
- CI*Rank ⋔ : 28 (10, 35)
- Percent of Cases with Late Stage : 66.4
Kentucky3
- Rate : The incidence rate is 13.6 with a 95% confidence interval from 13.2 to 14.1 and 750 average annual cases over 2017-2021.
- CI*Rank ⋔ : 5 (2, 14)
- Percent of Cases with Late Stage : 69.9
Louisiana3
- Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.2 to 13.1 and 682 average annual cases over 2017-2021.
- CI*Rank ⋔ : 18 (8, 31)
- Percent of Cases with Late Stage : 66.9
Maine6
- Rate : The incidence rate is 13.6 with a 95% confidence interval from 12.9 to 14.4 and 271 average annual cases over 2017-2021.
- CI*Rank ⋔ : 4 (1, 22)
- Percent of Cases with Late Stage : 70.2
Maryland6
- Rate : The incidence rate is 11.8 with a 95% confidence interval from 11.4 to 12.2 and 864 average annual cases over 2017-2021.
- CI*Rank ⋔ : 34 (24, 37)
- Percent of Cases with Late Stage : 67.7
Michigan6
- Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.2 to 12.8 and 1,580 average annual cases over 2017-2021.
- CI*Rank ⋔ : 21 (12, 30)
- Percent of Cases with Late Stage : 67.8
Minnesota6
- Rate : The incidence rate is 14.1 with a 95% confidence interval from 13.6 to 14.5 and 963 average annual cases over 2017-2021.
- CI*Rank ⋔ : 3 (1, 8)
- Percent of Cases with Late Stage : 63.6
Mississippi6
- Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.7 to 10.7 and 356 average annual cases over 2017-2021.
- CI*Rank ⋔ : 43 (38, 47)
- Percent of Cases with Late Stage : 62.8
Missouri6
- Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.3 to 13.1 and 974 average annual cases over 2017-2021.
- CI*Rank ⋔ : 17 (8, 29)
- Percent of Cases with Late Stage : 70.2
Montana6
- Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.5 to 13.2 and 176 average annual cases over 2017-2021.
- CI*Rank ⋔ : 26 (5, 38)
- Percent of Cases with Late Stage : 70.9
Nebraska6
- Rate : The incidence rate is 12.8 with a 95% confidence interval from 12.1 to 13.5 and 291 average annual cases over 2017-2021.
- CI*Rank ⋔ : 15 (4, 33)
- Percent of Cases with Late Stage : 66.0
Nevada6
- Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.8 to 8.7 and 295 average annual cases over 2017-2021.
- CI*Rank ⋔ : 49 (48, 50)
- Percent of Cases with Late Stage : 56.6
New Hampshire6
- Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.8 to 13.3 and 231 average annual cases over 2017-2021.
- CI*Rank ⋔ : 20 (5, 36)
- Percent of Cases with Late Stage : 62.5
New Jersey3
- Rate : The incidence rate is 12.9 with a 95% confidence interval from 12.6 to 13.2 and 1,462 average annual cases over 2017-2021.
- CI*Rank ⋔ : 12 (7, 24)
- Percent of Cases with Late Stage : 62.0
New Mexico3
- Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.4 to 8.4 and 208 average annual cases over 2017-2021.
- CI*Rank ⋔ : 50 (48, 50)
- Percent of Cases with Late Stage : 55.5
New York3
- Rate : The incidence rate is 12.9 with a 95% confidence interval from 12.7 to 13.1 and 3,185 average annual cases over 2017-2021.
- CI*Rank ⋔ : 13 (8, 22)
- Percent of Cases with Late Stage : 63.4
North Carolina6
- Rate : The incidence rate is 12.4 with a 95% confidence interval from 12.1 to 12.7 and 1,550 average annual cases over 2017-2021.
- CI*Rank ⋔ : 25 (14, 30)
- Percent of Cases with Late Stage : 69.1
North Dakota6
- Rate : The incidence rate is 13.2 with a 95% confidence interval from 12.1 to 14.3 and 116 average annual cases over 2017-2021.
- CI*Rank ⋔ : 10 (1, 35)
- Percent of Cases with Late Stage : 68.0
Ohio6
- Rate : The incidence rate is 13.4 with a 95% confidence interval from 13.1 to 13.7 and 1,982 average annual cases over 2017-2021.
- CI*Rank ⋔ : 7 (4, 13)
- Percent of Cases with Late Stage : 70.4
Oklahoma6
- Rate : The incidence rate is 11.4 with a 95% confidence interval from 11.0 to 11.9 and 525 average annual cases over 2017-2021.
- CI*Rank ⋔ : 36 (28, 40)
- Percent of Cases with Late Stage : 65.9
Oregon6
- Rate : The incidence rate is 11.8 with a 95% confidence interval from 11.4 to 12.3 and 629 average annual cases over 2017-2021.
- CI*Rank ⋔ : 33 (22, 37)
- Percent of Cases with Late Stage : 66.0
Pennsylvania6
- Rate : The incidence rate is 13.1 with a 95% confidence interval from 12.8 to 13.4 and 2,241 average annual cases over 2017-2021.
- CI*Rank ⋔ : 11 (5, 18)
- Percent of Cases with Late Stage : 68.2
Rhode Island6
- Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.5 to 13.2 and 171 average annual cases over 2017-2021.
- CI*Rank ⋔ : 27 (6, 38)
- Percent of Cases with Late Stage : 66.4
South Carolina6
- Rate : The incidence rate is 10.3 with a 95% confidence interval from 9.9 to 10.6 and 656 average annual cases over 2017-2021.
- CI*Rank ⋔ : 42 (39, 46)
- Percent of Cases with Late Stage : 64.9
South Dakota6
- Rate : The incidence rate is 13.3 with a 95% confidence interval from 12.3 to 14.3 and 143 average annual cases over 2017-2021.
- CI*Rank ⋔ : 9 (1, 33)
- Percent of Cases with Late Stage : 69.2
Tennessee6
- Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.8 and 871 average annual cases over 2017-2021.
- CI*Rank ⋔ : 41 (38, 45)
- Percent of Cases with Late Stage : 60.8
Texas3
- Rate : The incidence rate is 11.0 with a 95% confidence interval from 10.8 to 11.1 and 3,177 average annual cases over 2017-2021.
- CI*Rank ⋔ : 38 (36, 40)
- Percent of Cases with Late Stage : 62.5
Utah3
- Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.0 to 13.2 and 362 average annual cases over 2017-2021.
- CI*Rank ⋔ : 19 (6, 33)
- Percent of Cases with Late Stage : 68.2
Vermont6
- Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.4 to 13.6 and 114 average annual cases over 2017-2021.
- CI*Rank ⋔ : 22 (3, 39)
- Percent of Cases with Late Stage : 67.6
Virginia6
- Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.8 and 1,062 average annual cases over 2017-2021.
- CI*Rank ⋔ : 40 (38, 44)
- Percent of Cases with Late Stage : 64.2
Washington5
- Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.1 to 12.8 and 1,107 average annual cases over 2017-2021.
- CI*Rank ⋔ : 23 (12, 31)
- Percent of Cases with Late Stage : 65.7
West Virginia6
- Rate : The incidence rate is 13.6 with a 95% confidence interval from 12.9 to 14.3 and 341 average annual cases over 2017-2021.
- CI*Rank ⋔ : 6 (2, 21)
- Percent of Cases with Late Stage : 69.8
Wisconsin6
- Rate : The incidence rate is 14.2 with a 95% confidence interval from 13.8 to 14.6 and 1,057 average annual cases over 2017-2021.
- CI*Rank ⋔ : 2 (1, 6)
- Percent of Cases with Late Stage : 69.8
Wyoming6
- Rate : The incidence rate is 9.6 with a 95% confidence interval from 8.5 to 10.7 and 67 average annual cases over 2017-2021.
- CI*Rank ⋔ : 46 (37, 49)
- Percent of Cases with Late Stage : 60.0
- Rate : Data not available for this combination of data selections.
- CI*Rank ⋔ : N/A
- Percent of Cases with Late Stage : data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/03/2024 3:36 pm.
State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.
^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Data not available for this combination of data selections.
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
3 Source: SEER November 2023 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2023 submission).
Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.